Itinerant Itin leaves Micromet for refuelled Cytos
This article was originally published in Scrip
Dr Christian Itin has left his position as president and CEO of Micromet, a company acquired by Amgen in January for £1.1 billion, to join Swiss company Cytos Biotechnology as CEO.
You may also be interested in...
Almirall has launched its irritable bowel syndrome drug Constella (linaclotide) in six European countries, with several other launches planned for later this year.
Dermira, a dermatology-focused biotech, has raised $35m in a series B financing.
Clovis Oncology has raised its public offering, announced 11 June, from $170m to $240m.